FOXP3 expression in GARP-transduced helper T cells is not associated with FOXP3 TSDR demethylation

Transfusion Medicine and Hemotherapy

Volumn 38, Issue 5, 2011, Pages 287-291

  Kehrmann, Jan ^a   Zeschnigk, Michael ^b   Buer, Jan ^a   Probst Kepper, Michael ^c  

^a Institut für Medizinische Mikrobiologie   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c KLINIKUM BRAUNSCHWEIG   (Germany)

Author keywords

FOXP3; GARP; LRRC32; Regulatory T cells; TSDR

Indexed keywords

BISULFITE; GENOMIC DNA; GLYCOPROTEIN; GLYCOPROTEIN A REPETITIONS PREDOMINANT; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNE DISEASE; CELL THERAPY; DEMETHYLATION; DNA METHYLATION; DNA MODIFICATION; HELPER CELL; HUMAN; HUMAN CELL; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; UPREGULATION;

EID: 80053549341     PISSN: 16603796     EISSN: 16603818     Source Type: Journal    
DOI: 10.1159/000331499     Document Type: Article

References (31)

1. Miyara M, Wing K, Sakaguchi S: Therapeutic approaches to allergy and autoimmunity based on FoxP3+ regulatory T-cell activation and expansion. J Allergy Clin Immunol 2009;123:749-55.
2. Probst-Kepper M, Kröger A, Garritsen HSP, Buer J: Perspectives on regulatory T cell therapies. Transfus Med Hemother 2009;36:302-8.
3. Floess S, Freyer J, Siewert C, Baron U, Olek S, Polansky J, Schlawe K, Chang HD, Bopp T, Schmitt E, Klein-Hessling S, Serfling E, Hamann A, Huehn J: Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol 2007;5:e38.
4. Janson PC, Winerdal ME, Marits P, Thorn M, Ohlsson R, Winqvist O: FOXP3 promoter demethylation reveals the committed Treg population in humans. PLoS ONE 2008;3:e1612.
5. Huehn J, Polansky JK, Hamann A: Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage? Nat Rev Immunol 2009;9: 83-9.
6. Liu J, Lluis A, Illi S, Layland L, Olek S, von Mutius E, Schaub B: T regulatory cells in cord blood - FOXP3 demethylation as reliable quantitative marker. PLoS ONE 2010;5:e13267.
7. Stockis J, Fink W, Francois V, Connerotte T, de Smet C, Knoops L, van der Bruggen P, Coulie PG, Lucas S: Comparison of stable human Treg and Th clones by transcriptional profiling. Eur J Immunol 2009;39:869-82.
8. François V, Ottaviani S, Renkvist N, Stockis J, Schuler G, Thielemans K, Colau D, Marchand M, Boon T, Lucas S, van der Bruggen P: The CD4+ T-cell response of melanoma patients to a MAGEA3 peptide vaccine involves potential regulatory T cells. Cancer Res 2009;69:4335-45.
9. Polansky JK, Schreiber L, Thelemann C, Ludwig L, Kruger M, Baumgrass R, Cording S, Floess S, Hamann A, Huehn J: Methylation matters: binding of Ets-1 to the demethylated Foxp3 gene contributes to the stabilization of Foxp3 expression in regulatory T cells. J Mol Med 2010;88:1029-40.
10. Wang R, Wan Q, Kozhaya L, Fujii H, Unutmaz D: Identification of a regulatory T cell specific cell surface molecule that mediates suppressive signals and induces Foxp3 expression. PLoS One 2008;3:e27705.
11. Wang R, Kozhaya L, Mercer F, Khaitan A, Fujii H, Unutmaz D: Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells. Proc Natl Acad Sci U S A 2009;106:13439-44.
12. Probst-Kepper M, Geffers R, Kröger A, Viegas N, Erck C, Hecht HJ, Lünsdorf H, Roubin R, Moharregh-Khiabani D, Wagner K, Ocklenburg F, Jeron A, Garritsen H, Arstila TP, Kekäläinen E, Balling R, Hauser H, Buer J, Weiss S: GARP: a key receptor controlling FOXP3 in human regulatory T cells. J Cell Mol Med 2009;13:3343-57.
13. Stockis J, Colau D, Coulie PG, Lucas S: Membrane protein GARP is a receptor for latent TGF-β on the surface of activated human Treg. Eur J Immunol 2009;39:3315-22.
14. Tran DQ, Andersson J, Wang R, Ramsey H, Unutmaz D, Shevach EM: GARP (LRRC32) is essential for the surface expression of latent TGF-βon platelets and activated FOXP3+ regulatory T cells. Proc Natl Acad Sci U S A 2009;106:13445-50.
15. Probst-Kepper M, Balling R, Buer J: FOXP3: required but not sufficient. the role of GARP (LRRC32) as a safeguard of the regulatory phenotype. Curr Mol Med 2010;10:533-9.
16. Battaglia M, Roncarolo MG: The Tregs' world according to GARP. Eur J Immunol 2009;39:3296-300.
17. Schmidl C, Klug M, Boeld TJ, Andreesen R, Hoffmann P, Edinger M, Rehli M: Lineage-specific DNA methylation in T cells correlates with histone methylation and enhancer activity. Genome Res 2009;19:1165-74.
18. Lei J, Hasegawa H, Matsumoto T, Yasukawa M: Peroxisome proliferator-activated receptor and agonists together with TGF-βconvert human CD4+CD25- T cells into functional Foxp3+ regulatory T cells. J Immunol 2010;185:7186-98.
19. Ocklenburg F, Moharregh-Khiabani D, Geffers R, Janke V, Pfoertner S, Garritsen H, Groebe L, Klempnauer J, Dittmar KE, Weiss S, Buer, Probst-Kepper M: UBD, a downstream element of FOXP3, allows the identification of LGALS3, a new marker of human regulatory T cells. Lab Invest 2006;86:724-37. (Pubitemid 43901669)
20. Pfoertner S, Jeron A, Probst-Kepper M, Guzman CA, Hansen W, Westendorf AM, Toepfer T, Schrader AJ, Franzke A, Buer J, Geffers R: Signatures of human regulatory T cells: an encounter with old friends and new players. Genome Biol 2006;7:R54.
21. Don RH, Cox PT, Wainwright BJ, Baker K, Mattick JS: 'Touchdown' PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res 1991;19:4008.
22. Baron U, Floess S, Wieczorek G, Baumann K, Grutzkau A, Dong J, Thiel A, Boeld TJ, Hoffmann P, Edinger M, Turbachova I, Hamann A, Olek S, Huehn J: DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. Eur J Immunol 2007;37:2378-89. (Pubitemid 47423608)
23. Ronan A, Buiting K, Dudding T: Atypical Angelman syndrome with macrocephaly due to a familial imprinting center deletion. Am J Med Genet A 2008;146A:78-82.
24. Hochedlinger K, Plath K: Epigenetic reprogramming and induced pluripotency. Development 2009;136:509-23.
25. Allan SE, Broady R, Gregori S, Himmel ME, Locke N, Roncarolo MG, Bacchetta R, Levings MK: CD4+ T-regulatory cells: toward therapy for human diseases. Immunol Rev 2008;223:391-421. (Pubitemid 351986179)
26. Loser K, Hansen W, Apelt J, Balkow S, Buer J, Beissert S: In vitro generated regulatory T cells induced by Foxp3-retrovirus infection control murine contact allergy and systemic autoimmunity. Gene Ther 2005;12:1294-304. (Pubitemid 43084485)
27. Jaeckel E, von Boehmer H, Manns MP: Antigenspecific FoxP3-transduced T-cells can control established type 1 diabetes. Diabetes 2005;54:306-10.
28. Hansen W, Loser K, Westendorf AM, Bruder D, Pfoertner S, Siewert C, Huehn J, Beissert S, Buer J: G protein-coupled receptor 83 overexpression in naive CD4+CD25- T cells leads to the induction of Foxp3+ regulatory T cells in vivo. J Immunol 2006; 177:209-15. (Pubitemid 43939132)
29. Hansen W, Westendorf AM, Toepfer T, Mauel S, Geffers R, Gruber AD, Buer J: Inflammation in vivo is modulated by GPR83 isoform-4 but not GPR83 isoform-1 expression in regulatory T cells. Genes Immun 2010;11:357-61.
30. Reinwald S, Wiethe C, Westendorf AM, Breloer M, Probst-Kepper M, Fleischer B, Steinkasserer A, Buer J, Hansen W: CD83 expression in CD4+ T cells modulates inflammation and autoimmunity. J Immunol 2008;180:5890-7.
31. Ziegler SF: FOXP3: of mice and men. Annu Rev Immunol 2006;24:209-26.